CBFA2T3 and breast cancer: In fact, loss of heterozygosity (LOH) at the CBFA2T3 locus (16q24.3) is observed in an estimated 36–67% of ductal carcinomas, and ectopic overexpression of MTG16 in breast cancer cell lines inhibits their colony formation [83].